Financial Gravity Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.39K Sell
192
-704
-79% -$18.7K ﹤0.01% 651
2025
Q4
$22.3K Sell
896
-63
-7% -$1.59K ﹤0.01% 362
2025
Q3
$24.4K Buy
+959
New +$23.7K ﹤0.01% 391
2025
Q1
$23.7K Buy
+937
New +$24.5K 0.01% 451
2024
Q2
$7.86K Sell
281
-116
-29% -$3.19K ﹤0.01% 533
2024
Q1
$11.3K Sell
397
-5
-1% -$139 ﹤0.01% 449
2023
Q4
$11.6K Buy
+402
New +$12.2K ﹤0.01% 456
2021
Q3
$43K Sell
8
-2
-20% -$89 0.02% 623
2021
Q2
$39K Buy
+10
New +$389 0.01% 648
2020
Q4
$1K Buy
+17
New +$624 ﹤0.01% 434
2019
Q4
$55K Sell
600
-302
-33% -$10.8K 0.04% 593
2019
Q3
$31K Sell
902
-185
-17% -$6.73K 0.03% 376
2019
Q2
$45K Buy
1,087
+271
+33% +$10.8K 0.04% 339
2019
Q1
$33K Buy
+816
New +$32.7K 0.03% 377
2018
Q3
$304K Sell
7,409
-987
-12% -$38K 0.32% 53
2018
Q2
$326K Buy
8,396
+260
+3% +$8.88K 0.31% 51
2018
Q1
$269K Buy
+8,136
New +$280K 0.28% 62

Other funds holding PFE

Financial Gravity Asset Management's PFE Position: Q1 2026 in Review

Financial Gravity Asset Management reduced its Pfizer (PFE) stake by 79% in Q1 2026, selling an estimated $18.7K and leaving 192 shares worth $5.39K. The position accounts for ﹤0.01% of the portfolio, ranked #651.

Financial Gravity Asset Management first reported a position in PFE in Q1 2018 and has held it in 17 quarters since. The position peaked at $326K in Q2 2018. 2,953 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Financial Gravity Asset Management held 192 shares of Pfizer worth $5.39K as of Q1 2026.
  • Financial Gravity Asset Management sold 704 Pfizer shares in Q1 2026, an estimated $18.7K.
  • Pfizer made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q1 2026, its #651 holding.
  • Financial Gravity Asset Management first reported a position in Pfizer in Q1 2018 and has held it in 17 quarters since.
  • Financial Gravity Asset Management's Pfizer position peaked at $326K in Q2 2018.
  • 2,953 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Financial Gravity Asset Management's 13F filing for Q1 2026, filed 8 May 2026.